BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This advanced multi-phase engineered formulation features doxorubicin hydrochloride loaded liquid fluorocarbon emulsions enclosed within a lipid shell. The complex architecture consists of a high-purity phospholipid bilayer envelope that encapsulates an emulsified liquid fluorocarbon core (such as perfluorooctyl bromide or perfluorohexane) alongside the hydrophilic anthracycline doxorubicin hydrochloride. This unique combination coordinates the exceptionally high oxygen-dissolving and acoustic-responsive vaporizable parameters of a liquid fluorocarbon core with the protective matrix of a lipid envelope, preventing the rapid crystallization of the anthracycline while establishing a stable multi-phase reference standard for mechanical fluid mapping.
Source
Custom synthesis
Functional Group
Doxorubicin hydrochloride; Liquid fluorocarbon
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.